- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06063135
Effects of Physical Exercise Timing On Strength and Cardiometabolic Health (EPOCH)
June 24, 2025 updated by: Raphael Knaier, University of Basel
Physical exercise is well known to improve human health.
Current guidelines provide recommendations on the frequency, intensity, type and duration of exercise.
However, they do not provide recommendations for the time of day, exercise should be performed.
This is surprising considering that the influence of timing of behaviors such as sleep or nutrition as well as the impact of the circadian timing system on health are well documented.
Further, there is evidence for diurnal variation in maximum performance which enables individuals to exercise with different intensities at different times of day, which in the long term might affect physical adaptations to exercise.
Thus, this research study investigates if exercise timing impacts human health.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
152
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Basel, Switzerland, 4052
- University of Basel
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- BMI 18.5 - 30 kg/m2
Exclusion Criteria:
- Structured resistance training within the last six months
- Ongoing shift work
- Irregular bedtime (> 2 hours variation in habitual bed time)
- Smoking
- Travels across more than two time zones within the last four weeks
- Inability to follow the study procedures (e.g. due to language barriers, psychological disorders, dementia, etc.)
- Known pregnancy or lactating women
- Participation in any other clinical trial within the last four weeks
- Medical condition that is a contra indicator for resistance training, endurance training, or exercising until maximum exhaustion including insufficiently controlled blood pressure (systolic > 170 mmHg, diastolic > 100 mmHg), ongoing cancer treatment, unstable angina pectoris, uncontrolled bradyarrhythmia or tachyarrhythmia, severe uncorrected valvular heart disease, clinically relevant acute infection, any form of musculoskeletal injury, orthopedic problems or decompensated cardiovascular disease
- Insulin dependent diabetes
- Participants using metformin
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
Single life-style coaching session
|
|
|
Experimental: Exercise Time 1
Physical exercise intervention taking place at one time of the day
|
Two strength training session per week and one endurance training session per week
|
|
Experimental: Exercise Time 2
Physical exercise intervention taking place at another time of day
|
Two strength training session per week and one endurance training session per week
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Maximum strength
Time Frame: Pre-Intervention (i.e. 1 to 28 days before the first training session of the exercise intervention) and Post-Intervention (i.e. 1 to 28 days after the last training session of the exercise intervention)
|
Mean value of the maximum isometric strength assessed at four different times of the day with an isometric mid-thigh pull on a force plate.
|
Pre-Intervention (i.e. 1 to 28 days before the first training session of the exercise intervention) and Post-Intervention (i.e. 1 to 28 days after the last training session of the exercise intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body composition
Time Frame: Pre-Intervention (i.e. 1 to 28 days before the first training session of the exercise intervention) and Post-Intervention (i.e. 1 to 28 days after the last training session of the exercise intervention)
|
total body fat mass assessed with DXA
|
Pre-Intervention (i.e. 1 to 28 days before the first training session of the exercise intervention) and Post-Intervention (i.e. 1 to 28 days after the last training session of the exercise intervention)
|
|
Cardiorespiratory fitness
Time Frame: Pre-Intervention (i.e. 1 to 28 days before the first training session of the exercise intervention) and Post-Intervention (i.e. 1 to 28 days after the last training session of the exercise intervention)
|
VO2max assessed with cardiopulmonary exercise test
|
Pre-Intervention (i.e. 1 to 28 days before the first training session of the exercise intervention) and Post-Intervention (i.e. 1 to 28 days after the last training session of the exercise intervention)
|
|
Glucose control
Time Frame: Pre-Intervention (i.e. 1 to 28 days before the first training session of the exercise intervention) and Post-Intervention (i.e. 1 to 28 days after the last training session of the exercise intervention)
|
2-h postprandial area under the curve for glucose after an oral glucose tolerance test
|
Pre-Intervention (i.e. 1 to 28 days before the first training session of the exercise intervention) and Post-Intervention (i.e. 1 to 28 days after the last training session of the exercise intervention)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Raphael Knaier, PhD, University of Basel
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 21, 2023
Primary Completion (Actual)
June 24, 2025
Study Completion (Actual)
June 24, 2025
Study Registration Dates
First Submitted
September 18, 2023
First Submitted That Met QC Criteria
September 25, 2023
First Posted (Actual)
October 2, 2023
Study Record Updates
Last Update Posted (Estimated)
June 25, 2025
Last Update Submitted That Met QC Criteria
June 24, 2025
Last Verified
June 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- EPOCH
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Anonymized data will be provided in a data repository in accordance to FAIR principles
IPD Sharing Time Frame
After completion of study
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Physical Inactivity
-
Bess MarcusNational Heart, Lung, and Blood Institute (NHLBI); Lifespan/ The Miriam HospitalRecruitingInactivity | Inactivity, Physical | Inactivity/Low Levels of ExerciseUnited States
-
Chinese University of Hong KongNot yet recruitingPhysical InactivityHong Kong
-
Brown UniversityNational Cancer Institute (NCI)Recruiting
-
University of Milano BicoccaFederico II University; University of BergamoRecruitingPhysical InactivityItaly
-
University of CalgaryPublic Health Agency of Canada (PHAC)Recruiting
-
University of MinnesotaCompletedPhysical InactivityUnited States
-
Universiti Putra MalaysiaCompletedInactivity, PhysicalPakistan
-
Ludwig Boltzmann Institute for Digital Health and...CompletedPhysical InactivityAustria
-
Brown UniversityNational Institute of General Medical Sciences (NIGMS)CompletedPhysical InactivityUnited States
-
Clemson UniversityPrisma Health-Upstate; YMCACompleted
Clinical Trials on Physical Exercise Intervention
-
Tigers Running ClubCompletedBreast Cancer | Cancer SurvivorsSpain
-
Fundacion Miguel ServetUniversidad Pública de Navarra; Complejo Hospitalario de NavarraCompletedFrailty | Disability Physical | Hospital Acquired ConditionSpain
-
Asociación Española contra el CáncerCompletedCancer Patients in Different StagesSpain
-
Institute VerbeetenCZ Fonds; Verbeeten Fonds; Stichting Fight CancerRecruiting
-
VA Office of Research and DevelopmentActive, not recruiting
-
Brigham and Women's HospitalUniversity of California, Davis; University of South Carolina; Society and Health... and other collaboratorsRecruitingBehavioral and Psychological Symptoms of Dementia (BPSD)Thailand
-
Milton S. Hershey Medical CenterNational Heart, Lung, and Blood Institute (NHLBI); Thomas Jefferson UniversityCompleted
-
Oslo University HospitalThe Research Council of Norway; St. Olavs HospitalActive, not recruitingStage I Breast Cancer | Stage II Breast Cancer | DCIS Grade 3 | LCIS, Lobular Carcinoma in SituNorway
-
University of California, IrvineMassachusetts General Hospital; University of Missouri-ColumbiaCompletedControl Condition | Physical Exercise ConditionUnited States
-
Mgr. Eliška VrátnáVladimíra Fejfarová, MD, PhD; prof. Ing. Václav Bunc, CScUnknownPrevention of Diabetic FootCzechia